Morgan Stanley raised the firm’s price target on Curtiss-Wright (CW) to $395 from $334 and keeps an Overweight rating on the shares. Another “beat-and-raise” quarter “deepens our conviction in CW as a high-quality player in a scarce pool of A&D smid-caps,” the analyst tells investors. Recent commercial nuclear power commitments support sentiment, while continued execution in core aerospace and defense end markets de-risk the targets presented at the company’s investor day, the analyst argues in a post-earnings note.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CW:
- Curtiss-Wright price target raised to $333 from $304 at Truist
- Curtiss-Wright Reports Strong Q3 2024 Results and Raises Guidance
- Curtiss-Wright raises FY24 adjusted EPS view to $10.55-$10.75 from $10.40-$10.65
- Curtiss-Wright reports Q3 adjusted EPS $2.97, consensus $2.70
- Curtiss-Wright initiated with an Overweight at Alembic Global